Congestive heart failure induces endothelial cell apoptosis: Protective role of carvedilol

Journal of the American College of Cardiology

Volumn 36, Issue 7, 2000, Pages 2081-2089

  Rössig, Lothar ^a   Haendeler, Judith ^a   Mallat, Ziad ^b   Hugel, Benedicte ^c   Freyssinet, Jean Marie ^c   Tedgui, Alain ^b   Dimmeler, Stefanie ^a   Zeiher, Andreas M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HÔPITAL LARIBOISIÈRE   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; CASPASE; CYTOCHROME C; DNA; MITOGEN ACTIVATED PROTEIN KINASE; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AGE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONCENTRATION RESPONSE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; FLUORESCENCE; GENDER; HEART PROTECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTIOXIDANTS; APOPTOSIS; CARBAZOLES; CELLS, CULTURED; CYTOCHROME C GROUP; EPITHELIAL CELLS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES;

EID: 0033662177     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01002-0     Document Type: Article

References (38)

1. Alterations in vasomotor tone in congestive heart failure
2. Mechanisms of exercise intolerance in congestive heart failure
3. Factors contributing to the exercise limitation of heart failure
4. Endothelium-dependent vasodilation is attenuated in patients with heart failure
5. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure
6. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure
7. Basic mechanisms in congestive heart failure: Recognizing the role of proinflammatory cytokines
8. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
9. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
10. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
11. Elevated circulating levels of C-C chemokines in patients with congestive heart failure
12. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases
13. 2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase
14. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation
15. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro
16. Life, death, and the pursuit of apoptosis
17. Caspases: Enemies within
18. Cytochrome c: Can't live with it, can't live without it
19. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
20. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
21. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: Role of tumor necrosis factor-alpha
22. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
23. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: Involvement in suppression of apoptosis
24. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection
25. Nitric oxide inhibits APO-1/Fas-mediated cell death
26. Cyclosporine A inhibits apoptosis of human endothelial cells by preventing the release of cytochrome c from mitochondria
27. Possible involvement of stress-activated protein kinase signaling pathway and fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol
28. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
29. Tumor necrosis factor-alpha and cardiomyopathy
30. Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: A mechanistic clue to the response to injury hypothesis
31. Angiotensin II induces apoptosis of human endothelial cells: Protective effect of nitric oxide
32. Increased oxidative stress in patients with congestive heart failure
33. Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure
34. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
35. Carvedilol: Preclinical profile and mechanisms of action in preventing the progression of congestive heart failure
36. Apoptosis in the failing human heart
37. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids
38. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure